Skip to main content

Table 3 Calculated ARG1-D case number and population prevalence by country

From: Arginase 1 Deficiency: using genetic databases as a tool to establish global prevalence

Country

Population 2021 (1000 s)

Estimated ARG1-D cases

ARG1-D population prevalence (cases/million)

Argentina

45,914

70

1.53

Australia

25,700

14

0.56

Austria

8801

5

0.60

Bahrain

1744

5

3.02

Belgium

11,669

9

0.73

Brazil

215,278

312

1.45

Canada

37,924

37

0.97

Chile

18,605

31

1.67

Colombia

50,576

95

1.88

Croatia

4092

2

0.47

Czech Republic

10,634

5

0.47

Denmark

5819

5

0.80

Finland

5599

3

0.48

France

65,955

51

0.77

Germany

82,591

52

0.64

Ireland

4926

3

0.59

Israel

8842

34

3.90

Italy

59,038

36

0.61

Japan

126,109

306

2.43

South Korea

51,667

44

0.85

Kuwait

4361

28

6.49

Mexico

135,384

193

1.43

Netherlands

17,230

9

0.51

New Zealand

4876

3

0.52

Norway

5500

3

0.46

Poland

37,847

22

0.59

Portugal

10,183

9

0.90

Qatar

2840

25

8.74

Russia

143,637

93

0.65

Saudi Arabia

35,263

258

7.32

Spain

46,450

81

1.73

Sweden

10,188

6

0.60

Switzerland

8731

5

0.60

Taiwan

23,873

38

1.58

Turkey

84,515

267

3.16

UAE

9937

64

6.40

UK

67,699

39

0.58

United States

333,783

250

0.75

Total (38 countries)

1,823,780

2511

1.38